Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-04-30 Sale | 2022-05-03 5:19 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 254 | $6.62 | $1,681 | 24,967 (Direct) | View |
| 2022-01-31 Sale | 2022-02-02 4:35 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 414 | $7.58 | $3,138 | 46,616 (Direct) | View |
| 2022-01-31 Sale | 2022-02-02 4:34 pm | UroGen Pharma Ltd. | URGN | Henderson Molly CFO | 331 | $7.58 | $2,509 | 44,082 (Direct) | View |
| 2022-01-31 Sale | 2022-02-02 4:33 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,374 | $7.58 | $10,415 | 45,285 (Direct) | View |
| 2022-01-31 Sale | 2022-02-02 4:32 pm | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 8,195 | $7.58 | $62,118 | 490,025 (Direct) | View |
| 2022-01-26 Sale | 2022-01-28 4:29 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 111 | $8.09 | $898 | 22,095 (Direct) | View |
| 2022-01-03 Sale | 2022-01-07 08:38 am | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 46,968 | $9.15 | $429,757 | 298,220 (Direct) | View |
| 2021-11-30 Sale | 2021-12-02 1:16 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 3,803 | $12.03 | $45,750 | 23,697 (Direct) | View |
| 2021-11-30 Sale | 2021-12-02 1:15 pm | UroGen Pharma Ltd. | URGN | Henderson Molly CFO | 2,587 | $12.03 | $31,122 | 14,913 (Direct) | View |
| 2021-11-18 Purchase | 2021-11-19 3:05 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 160 | $13.1 | $2,096 | 21,997 (Direct) | View |
| 2021-10-31 Sale | 2021-11-02 3:45 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 258 | $17.16 | $4,427 | 24,337 (Direct) | View |
| 2021-10-26 Sale | 2021-10-28 2:04 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 107 | $16.32 | $1,746 | 21,804 (Direct) | View |
| 2021-07-31 Sale | 2021-08-03 7:07 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 243 | $15.64 | $3,801 | 24,494 (Direct) | View |
| 2021-07-26 Sale | 2021-07-28 09:11 am | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 103 | $15.3 | $1,576 | 21,238 (Direct) | View |
| 2021-05-17 Purchase | 2021-05-18 11:36 am | UroGen Pharma Ltd. | URGN | Henderson Molly CFO | 2,500 | $15.85 | $39,625 | 2,500 (Direct) | View |
| 2021-05-17 Purchase | 2021-05-18 11:35 am | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 2,500 | $15.71 | $39,275 | 2,500 (Direct) | View |
| 2021-04-30 Sale | 2021-05-04 1:58 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 243 | $20 | $4,860 | 24,632 (Direct) | View |
| 2021-04-26 Sale | 2021-04-27 1:44 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 89 | $19.63 | $1,747 | 21,500 (Direct) | View |
| 2021-02-02 Sale | 2021-02-02 2:53 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,076 | $22.07 | $23,747 | 51,755 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-04-30 Exercise | 2022-05-03 5:19 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 500 | $0 | 24,967 (Direct) | View |
| 2022-03-25 Option Award | 2022-03-29 7:14 pm | N/A 2032-03-24 | UroGen Pharma Ltd. | URGN | Kim Dong CFO | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-03-25 Ownership | 2022-03-29 7:11 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Kim Dong CFO | 0 | $0 | 41,920 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 4:35 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 37,500 | $0 | 46,616 (Direct) | View |
| 2022-01-31 Exercise | 2022-02-02 4:35 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 833 | $0 | 46,616 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 4:34 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Henderson Molly CFO | 37,500 | $0 | 44,082 (Direct) | View |
| 2022-01-31 Exercise | 2022-02-02 4:34 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Henderson Molly CFO | 666 | $0 | 44,082 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 4:33 pm | N/A 2032-01-31 | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 16,064 | $0 | 45,285 (Direct) | View |
| 2022-01-31 Exercise | 2022-02-02 4:33 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 2,500 | $0 | 45,285 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 4:32 pm | N/A 2032-01-31 | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 150,000 | $0 | 490,025 (Direct) | View |
| 2022-01-31 Exercise | 2022-02-02 4:32 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 18,333 | $0 | 490,025 (Direct) | View |
| 2022-01-26 Exercise | 2022-01-28 4:29 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 209 | $0 | 22,095 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-07 08:38 am | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 105,689 | $0 | 298,220 (Direct) | View |
| 2021-11-30 Exercise | 2021-12-02 1:16 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 8,333 | $0 | 23,697 (Direct) | View |
| 2021-11-30 Exercise | 2021-12-02 1:15 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Henderson Molly CFO | 5,000 | $0 | 14,913 (Direct) | View |
| 2021-10-31 Exercise | 2021-11-02 3:45 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 500 | $0 | 24,337 (Direct) | View |
| 2021-10-26 Exercise | 2021-10-28 2:04 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 208 | $0 | 21,804 (Direct) | View |
| 2021-07-31 Exercise | 2021-08-03 7:07 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 500 | $0 | 24,494 (Direct) | View |
| 2021-07-26 Exercise | 2021-07-28 09:11 am | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 208 | $0 | 21,238 (Direct) | View |
| 2020-06-03(A) Exercise | 2021-07-12 6:59 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 61,652 | $0 | 1,205,551 (Direct) | View |
| 2020-02-03(A) Exercise | 2021-07-12 6:57 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 35,229 | $0 | 928,902 (Direct) | View |
| 2021-03-26(A) Exercise | 2021-06-09 1:47 pm | 2014-07-27 2021-07-27 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 3,241 | $0 | 245,452 (Direct) | View |
| 2021-03-26(A) Exercise | 2021-06-09 1:47 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 3,241 | $5 | 245,452 (Direct) | View |
| 2021-03-25(A) Exercise | 2021-06-09 1:46 pm | 2014-07-27 2021-07-27 | UroGen Pharma Ltd. | URGN | Nussbaum Ran Director | 1,030 | $0 | 1,431,717 (Indirect) | View |
| 2021-03-25(A) Exercise | 2021-06-09 1:46 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Nussbaum Ran Director | 1,030 | $5 | 1,431,717 (Indirect) | View |
| 2021-06-07 Option Award | 2021-06-09 1:45 pm | N/A 2031-06-07 | UroGen Pharma Ltd. | URGN | Cohen Fred E Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-09 1:44 pm | N/A 2031-06-06 | UroGen Pharma Ltd. | URGN | BUTITTA CYNTHIA M Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-09 1:43 pm | N/A 2031-06-06 | UroGen Pharma Ltd. | URGN | FALBERG KATHRYN E Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-09 1:43 pm | N/A 2031-06-06 | UroGen Pharma Ltd. | URGN | Tomasello Shawn Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-03-25 Option Award | 2021-06-09 1:42 pm | N/A 2031-06-06 | UroGen Pharma Ltd. | URGN | Nussbaum Ran Director | 10,000 | $0 | 1,443,928 (Indirect) | View |
| 2021-03-25 Exercise | 2021-06-09 1:42 pm | 2014-07-27 2021-07-27 | UroGen Pharma Ltd. | URGN | Nussbaum Ran Director | 2,211 | $0 | 1,443,928 (Indirect) | View |
| 2021-03-25 Exercise | 2021-06-09 1:42 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Nussbaum Ran Director | 2,211 | $5 | 1,443,928 (Indirect) | View |
| 2021-06-07 Option Award | 2021-06-09 1:41 pm | N/A 2031-06-06 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-09 1:41 pm | N/A 2031-06-06 | UroGen Pharma Ltd. | URGN | Holden Stuart Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-05 Option Award | 2021-06-08 2:33 pm | N/A 2031-05-31 | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-05 Option Award | 2021-06-08 2:33 pm | N/A 2031-05-31 | UroGen Pharma Ltd. | URGN | Henderson Molly CFO | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-01-03 Exercise | 2021-05-21 1:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 13,807 | $0 | 355,188 (Direct) | View |
| 2021-01-03 Tax Withholding | 2021-05-21 1:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 3,425 | $17.51 | 355,188 (Direct) | View |
| 2021-04-30 Exercise | 2021-05-04 1:58 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 500 | $0 | 24,632 (Direct) | View |
| 2021-04-26 Exercise | 2021-04-27 1:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 209 | $0 | 21,500 (Direct) | View |
| 2021-03-24 Exercise | 2021-04-22 5:19 pm | 2014-07-27 2021-07-27 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 3,241 | $0 | 245,452 (Direct) | View |
| 2021-03-24 Exercise | 2021-04-22 5:19 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 3,241 | $5 | 245,452 (Direct) | View |
| 2021-03-24 Exercise | 2021-04-22 5:18 pm | 2014-07-27 2021-07-27 | UroGen Pharma Ltd. | URGN | Nussbaum Ran Director | 1,030 | $0 | 1,465,199 (Indirect) | View |
| 2021-03-24 Exercise | 2021-04-22 5:18 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Nussbaum Ran Director | 1,030 | $5 | 1,465,199 (Indirect) | View |
| 2021-01-31 Option Award | 2021-02-02 3:57 pm | N/A 2031-01-30 | UroGen Pharma Ltd. | URGN | Henderson Molly CFO | 8,000 | $0 | 8,000 (Direct) | View |
| 2021-01-31 Option Award | 2021-02-02 3:55 pm | N/A 2031-01-30 | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 10,500 | $0 | 10,500 (Direct) | View |
| 2021-01-31 Option Award | 2021-02-02 2:54 pm | N/A 2031-01-31 | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 190,000 | $0 | 190,000 (Direct) | View |
| 2021-02-02 Option Award | 2021-02-02 2:53 pm | N/A 2031-01-31 | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 27,000 | $0 | 51,755 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-02 2:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 2,000 | $0 | 51,755 (Direct) | View |